| ||
| ||
Merck Cholesterol Drug Lowers Heart Attack In Kidney Patients - Quick Facts RTT News (RTTNews) - Merck & Co. Inc. (MRK: News ), Saturday indicated that its cholesterol-lowering medicine Vytorin reduced the possibility of heart attack, stroke and other cardiovascular problems by 16.1% in chronic kidney disease patients, when compared to ... See all stories on this topic » | ||
Dr. Anil Potti Resigns From Duke University Amid Study Reliability Concerns Medical News Today Dr. Anil Potti, a cancer researcher, resigned yesterday as concerns were voiced regarding his research after Duke University, where he works, starting checking whether his grant application had been done honestly. Potti resigned his associate professor ... See all stories on this topic » | ||
|
This as-it-happens Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment